President Donald Trump is bringing his billionaire CEO posse with him to China this week, including ...

Cellular Intelligence has licensed Novo Nordisk’s cell therapy programme for Parkinson’s disease, seven months after the Danish drugmaker wound down operations with the modality. Cellular Intelligence ...

The deal gives Cellular Intelligence control of a clinical-stage therapy designed to restore the dopamine-producing nerve ...

The startup, Cellular Intelligence, is gaining rights to the early-stage treatment and will be in charge of shepherding it ...

Last October, Novo Nordisk had shut down its cell therapy unit as part of a broader restructuring, discontinuing development ...

Meta CEO Mark Zuckerberg backed-Cellular Intelligence has acquired Danish drugmaker Novo Nordisk's cell therapy candidate for ...

Meta Platforms, Inc. (NASDAQ: META) is one of the stocks Jim Cramer shared his thoughts on as he discussed Big Tech’s AI ...

On Meta’s Q1 2026 earnings call, CFO Susan Li said the quiet part out loud. “We recently shared internally that we plan to ...

Meta was hot during its early glory days, but it's starting to look as though it's entered a long, inexorable death spiral.

Meta is reportedly building AI agents that can shop and handle tasks for users, with Instagram expected to play a major role ...

At a virtual gathering on May 7, historian John Meacham and copyright scholar Paul Goldstein joined Association of American ...

Since my last article was published, the stock declined almost 9% and clearly underperformed the broader market (the S&P 500 ...